
Toward a More Proactive Health Care System
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
BCG’s new data-driven, high-efficiency model allows sales reps to offer health care providers a personalized sales experience—unlocking tremendous shareholder value.
Biopharma and medtech companies must act now to ensure their ability to mitigate disruptions across the value chain.
BCG’s new annual report identifies the modalities that are progressing most rapidly and those that hold the greatest promise for patient outcomes and company revenues.
Biopharma companies can promote the success of product launches by initiating cross-functional collaboration on evidence generation early in the development process.
Hudson discusses the company’s commitment to reaching net zero emissions by 2045.
Francis discusses the role that Teva’s people are playing in the execution of the company’s new growth strategy.
Chief Commercial Officer Everett Cunningham describes Exact Sciences’ efforts to boost awareness of this deadly disease.
Some of BCG's best advice to help provider, payer, biopharma, and medtech executives address the challenges and changes affecting the health care sector.
A suite of improvement levers provides the basis for designing a health care payers’ customized productivity transformation.
A use case-based approach can help overcome the sometimes formidable barriers to digitizing care and the other aspects of hospital operations.
Lessons learned during COVID-19 present an opportunity to improve the US public health system. Expanding practitioners’ capacities in decision-making, communication, and working with data is a critical step.
To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.
Medtech management teams face an unfamiliar list of questions. The players that can successfully navigate the challenging terrain will be the winners of the 2020s.
The technology has a range of uses in medtech, and the main challenge is knowing how and where to start. Here are 60 ways to generate quick wins.
Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.
Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.
The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
Experts across BCG and BCG X talk about the trends and opportunities that lie ahead for the digital health care market.